Inventor · disambiguated record
Teresa Semeraro
Also filed as: SEMERARO TERESA
8 granted patents·3 pending applications·3 citations·filing 2015–2022
74Inventor score
Files withINDIVIOR UK LTD5CHRONOS THERAPEUTICS LTD3CHIESI FARM SPA1SHIRE INT GMBH1UNIV OREGON HEALTH & SCIENCE1
Top patents by PatentIndex Score
11 records- 0176US10000477B2Dopamine D3 receptor antagonist compoundsINDIVIOR UK LTD·Filed 2015·Granted Jun 19, 2018·2 cites·33 claims
- 0271US10273244B2Substituted hexahydropyrrolo[3,4-b]pyrroles and hexahydrocyclopenta[c]pyrroles as dopamine receptor modulatorsINDIVIOR UK LTD·Filed 2016·Granted Apr 30, 2019·1 cites·22 claims
- 0363US10654842B2Dopamine D3 receptor antagonist compoundsINDIVIOR UK LTD·Filed 2019·Granted May 19, 2020·0 cites·20 claims
- 0451US10584135B2Substituted 3,6-diazabicyclo[3.2.0]heptanesINDIVIOR UK LTD·Filed 2019·Granted Mar 10, 2020·0 cites·19 claims
- 0548US2025011299A1Pyridazinyl amino derivatives as alk5 inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 0645US2023174484A1Antagonists of gpr39 proteinUNIV OREGON HEALTH & SCIENCE·Filed 2021·Application pending·0 cites
- 0740US11660293B2Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonistsCHRONOS THERAPEUTICS LTD·Filed 2018·Granted May 30, 2023·0 cites·20 claims
- 0833US10577361B2Dopamine D3 receptor antagonists having a morpholine moietyINDIVIOR UK LTD·Filed 2016·Granted Mar 3, 2020·0 cites·18 claims
- 0929US9920053B2N-(hetero)aryl-substituted heteroyclic derivatives useful for the treatment of diseases or conditions related to the central nervous systemCHRONOS THERAPEUTICS LTD·Filed 2015·Granted Mar 20, 2018·0 cites·21 claims
- 1028US2017260185A12-[bis(4-fluorophenyl)methyl]-2,7-diazaspiro[4.5]decan-10-one derivatives and related compounds as inhibitors of the human dopamine-active-transporter (dat) protein for the treatment of e.g. attention deficit disorder (add)SHIRE INT GMBH·Filed 2015·Application pending·0 cites
- 1127US9908897B2Spirocyclic derivativesCHRONOS THERAPEUTICS LTD·Filed 2015·Granted Mar 6, 2018·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →